NDC 70000-0573 Bisacodyl

Bisacodyl

NDC Product Code 70000-0573

NDC 70000-0573-1

Package Description: 1 BLISTER PACK in 1 CARTON > 4 SUPPOSITORY in 1 BLISTER PACK

NDC 70000-0573-2

Package Description: 4 BLISTER PACK in 1 CARTON > 4 SUPPOSITORY in 1 BLISTER PACK

NDC Product Information

Bisacodyl with NDC 70000-0573 is a a human over the counter drug product labeled by Cardinal Health. The generic name of Bisacodyl is bisacodyl. The product's dosage form is suppository and is administered via rectal form.

Labeler Name: Cardinal Health

Dosage Form: Suppository - A solid body of various weights and shapes, adapted for introduction into the rectal orifice of the human body; they usually melt, soften, or dissolve at body temperature.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Bisacodyl Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • BISACODYL 10 mg/1

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • HYDROGENATED PALM KERNEL OIL (UNII: FM8D1RE2VP)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Rectal - Administration to the rectum.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Cardinal Health
Labeler Code: 70000
FDA Application Number: part334 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 05-19-2021 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2022 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N - NO What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

* Please review the disclaimer below.

Bisacodyl Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Active Ingredient (In Each Suppository)

Bisacodyl USP, 10mg

Purpose

Stimulant Laxative

Uses

  • For temporary relief of occasional constipationthis product generally produces bowel movement in 15 minutes to 1 hour

Warnings

For rectal use only.

Do Not Use Unless Directed By A Doctor

  • If abdominal pain, nausea or vomiting are presentfor longer than 1 week

Ask A Doctor Before Use If You Have

Noticed a sudden change in bowel habits that lasts over a perios of 2 weeks

When Using This Product

It may cause abdominal discomfort, faitness, rectal burning and mild cramps

Stop Use And Ask A Doctor If

You have rectal bleeding or fail to have a bowel movement after using this product. These may indicate a serious condition.

If Pregnant Or Breast Feeding,

Ask a health professional before use.

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

  • Detach one suppository from the stripremove wrapper before inserting into rectumcarefully insert one suppository well into the rectum, pointed end firstretain about 15 to 20 minutesadults and children 12 years of age and over - 1 suppository once dailychildren 6 to under 12 years of age - 1/2 suppository once dailychildren under 6 - do not use

Other Information

  • Store at room remperature do not to exceed 30ºC (86ºF)Lot No. & Exp. Date: see wrapper or box

Inactive Ingredients

Hydrogenated vegetable oil

Leader Bisacodyl Suppositories

LeaderBisSupp.jpgThe product package shown above represents a sample of that currently in use. Additional packaging may also be available.Bisacodyl SuppositoriesDistributed byMajor PharmaceuticalsLivonia, MI 48152

* Please review the disclaimer below.